Prudhvi Regula

Prudhvi Regula practices at Waverly Health Center in Waverly, Iowa, part of City of Waverly.

Prudhvi Regula's NPI, 1386139244, was assigned on June 24, 2018. Prudhvi Regula holds Iowa license MD-50891.

Prudhvi Regula's primary practice is Waverly Health Center, at 312 9th Street SW, Waverly, IA 50677 in Bremer County. The practice phone is (319) 352-4120.

Prudhvi Regula's primary practice is Waverly Health Center in Waverly, Iowa, part of City of Waverly. Prudhvi Regula is also affiliated with MercyOne Waterloo Medical Center. The medical group on file is MercyOne Waterloo OB/GYN. Dmand AI also links Prudhvi Regula to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Prudhvi Regula practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Prudhvi Regula's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Prudhvi Regula is licensed in Iowa.

CMS data shows 3,263 Medicare services from Prudhvi Regula across 8 procedure codes in 2024, for 104 Medicare patients. Medicare paid $22,870 for them. Every service was in an office.

CMS counts 104 Medicare patients who saw Prudhvi Regula in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.76, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Prudhvi Regula's median patient age at 47, with 63% women.

In 2024, Prudhvi Regula wrote 271 Medicare Part D claims for 90 patients. 81% of them were for generic drugs. CMS names the drug for 175 of them, across 6 drugs with 11 or more claims each, at $48,874 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Prudhvi Regula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Prudhvi Regula as offering telehealth.

Dmand AI links 6 papers to Prudhvi Regula, published from 2018 to 2023. 2022 was the busiest year, with 2. Prudhvi Regula has published most often in J Allergy Clin Immunol Glob. Prudhvi Regula's most frequent co-authors are Manish Ramesh, MBBS, PhD, Golda Hudes, MD and Elina Jerschow, MD.

CMS Open Payments shows 76 general payments to Prudhvi Regula from 13 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 99% of the total. Sanofi and Genzyme US Companies paid the most, $455.